- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02337075
PAthway To Health (PATH): Fostering Culturally Appropriate Physical Activities in Indigenous Communities (PATH)
PAthway To Health (PATH): Fostering Culturally Appropriate Physical Activities Using Digital Technology in Indigenous Communities
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Background: Promoting an active lifestyle is a priority identified by the communities served by KDC Health. Statistics Canada estimates obesity in one in four adults based on 2007-2009 data, with higher prevalence among Indigenous people compared to non-Aboriginal population (between 26% and 36% among adults living off-reserve and on-reserve, respectively). Furthermore, Indigenous people also report higher prevalence of obesity associated complications, including diabetes, cardiovascular disease, and arthritis. The association between physical inactivity and obesity suggests that increasing physical activity is important.
KDC Health offers a variety of free programs to community members, however, the use of these services has been low. KDC Health has previously partnered with the CIHR-funded IMPAKT project, and has expressed a strong interest in developing an intervention to improve health and wellness in the communities.
Objectives:
- To determine whether the PATH program can improve physical activity participation in the communities served by KDC Health.
- To assess the effect of this program on reducing sedentary time, and increasing the use of health promotion and wellness services offered by KDC Health
- To assess the correlation of physical activity levels and the secondary outcome measures among individuals who are living in the same household.
Methods: The investigators will conduct a community-based proof-of-concept randomized controlled trial (RCT) with 60 eligible participants. Only 1 member per household will be enrolled. If more than 1 member is interested, they will select 1 person by consensus or by a random draw.
After obtaining the baseline measures, participants will be randomly assigned to the 'Now Group' (target=30) or 'Later Group' (target=30).
The Now Group will participate in a brief education session held at the KDC Health Centre, use a wearable physical activity tracker (Fitbit Flex), and physical activity mentoring by a KDC Health Staff (the Activity Mentors). The Activity Mentors have received training for the project from the Principal Investigator. In Month 1-2, participants will meet with their Activity Mentor once every 2 weeks to review their physical activity status, activity goals, and the health programs available at the Centre. In Month 3-4, they will continue to use Fitbit Flex but will no longer have regular meetings with the Activity Mentor.
The Later Group will receive intervention two months later (i.e., Month 3-4).
The primary outcome measure will be the time spent in moderate/vigorous physical activity. In addition, time spent in sedentary behaviours will be recorded. Participants will wear a SenseWear Mini accelerometer for 7 days at baseline, 2 months, and 4 months. Secondary outcome measures include sedentary time measured with SenseWear Mini, health status that will be measured using the SF-36 (a generic measure of health-related quality of life), and body weight. Participants' use of KDC Health programs and their motivation to be physically active will also be recorded.
At the end of the program, participants will be interviewed for 30 minutes in person about their opinion on the intervention. Interviews will focus on 1) barriers/facilitators to being physically active, 2) their experience with the intervention, and 3) the nature of activities they engage in.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
British Columbia
-
Richmond, British Columbia, Canada, V6X 2C7
- Arthritis Research Canada
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria: Participants are eligible if they:
- Are a person from KDC Health Member Nations
- Are 19 years or older
- Have no health condition that prevents them from being physically active
- Are able to participate in a 4-month project -
Exclusion Criteria: Participants are not eligible to participate if they:
- Do not meet the criteria above
- Use medication that may impair activity tolerance (e.g., beta blockers),
- Are unable to provide informed consent -
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Onderzoek naar gezondheidsdiensten
- Toewijzing: Gerandomiseerd
- Interventioneel model: Crossover-opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: Now Group - PATH Program
The Now Group will receive the PATH program.
They will participate in a brief education session, use a wearable physical activity tracker, and physical activity mentoring by an Activity Mentors.
In Month 1 and 2, participants will meet with their Activity Mentor once every 2 weeks to review their physical activity status, activity goals, and the health programs available at the Centre.
In Month 3 and 4, they will continue to use physical activity tracker but will no longer have regular meetings with the Activity Mentor.
|
A brief education session, use of a wearable physical activity tracker, and physical activity mentoring by an Activity Mentor every 2 weeks.
|
Actieve vergelijker: Later Group
The Later Group will receive the PATH program in Month 1-2.
Intervention will be provided two months later (i.e., Month 3 and 4).
|
A brief education session, use of a wearable physical activity tracker, and physical activity mentoring by an Activity Mentor every 2 weeks.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Time spent in Moderate to Vigorous Physical Activity (MVPA), measured by SenseWear Mini accelerometer
Tijdsspanne: Change from baseline in Time spent in MVPA at 2 months and 4 months
|
Participants will wear a SenseWear Mini accelerometer for 7 days at baseline, and Months 2 and 4.
|
Change from baseline in Time spent in MVPA at 2 months and 4 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Time spent in sedentary behaviours, measured by SenseWear Mini accelerometer
Tijdsspanne: Change from baseline in time spent in sedentary behaviours at 2 months and 4 months
|
Participants will wear a SenseWear Mini accelerometer for 7 days at baseline, and Months 2 and 4.
|
Change from baseline in time spent in sedentary behaviours at 2 months and 4 months
|
Change in Health Status, measured by SF-36 Questionnaire
Tijdsspanne: Change from baseline health status at 2 months and 4 months
|
SF-36 Questionnaire
|
Change from baseline health status at 2 months and 4 months
|
Change in Body weight, measured by measured with a calibrated scale
Tijdsspanne: Change from baseline body weight at 2 months and 4 months
|
Measured with a calibrated scale
|
Change from baseline body weight at 2 months and 4 months
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Linda Li, PT, PhD, Arthritis Research Canada
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- H12-02526
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Gezond
-
University of LeicesterNational Institute for Health Research, United KingdomVoltooidPatiënten met hartfalen en behouden ejectiefractie - HFpEF | Patiënten met hartfalen met verminderde ejectiefractie - HFrEF | Healthy Controls Group - Leeftijd en geslacht afgestemd
-
University Hospital, GrenobleUniversity Hospital, Clermont-Ferrand; Grenoble Institut des NeurosciencesBeëindigdZiekte van Parkinson | Healthy Controls Group - Leeftijd en geslacht afgestemdFrankrijk
Klinische onderzoeken op PATH program
-
University of PennsylvaniaIndependence Blue CrossVoltooidGezondheid, subjectief | Gebruik van de gezondheidszorg | Afdeling spoedeisende hulpVerenigde Staten
-
Weill Medical College of Cornell UniversityCornell UniversityNog niet aan het wervenLast van mantelzorgersVerenigde Staten
-
Weill Medical College of Cornell UniversityNational Institute on Aging (NIA)WervingDepressie | Pijn | Cognitieve beperkingVerenigde Staten
-
Abbott Medical DevicesVoltooidTypische atriale flutterVerenigde Staten, Canada
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH)VoltooidDepressie | Dementie | GeriatrieVerenigde Staten
-
Perception Dynamics InstituteUniversity of California, San Diego; University of South AlabamaIngetrokkenLeeftijdsgerelateerde cognitieve achteruitgangVerenigde Staten
-
St Elizabeth HealthcarePATH Decision Support Software, LLCVoltooidSuikerziekteVerenigde Staten
-
University of UlsterUniversity College Cork; Dublin City University; Northern Ireland Chest Heart and...WervingLichamelijke inactiviteitVerenigd Koninkrijk
-
PATHVoltooidInjecties, intradermaalVerenigde Staten
-
Weill Medical College of Cornell UniversityJohns Hopkins University; Montefiore Medical Center; National Institute on Aging...Actief, niet wervendDepressie | Cognitieve beperkingVerenigde Staten